Clinician-Patient Communication in Lung Cancer Care

NCT02732834 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2026-02-05

No results posted yet for this study

Summary

The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.

Conditions

Interventions

BEHAVIORAL

Questionnaire

patients will fill out a questionnaire about their perceived stigma, satisfaction with communication, and psychological distress.

BEHAVIORAL

Patient Interview

Then they will participate in a brief in-person interview about their perceived stigma during the clinical consultation

BEHAVIORAL

Audio recordings of clinical consultations

BEHAVIORAL

Questionnaire

Patients will fill out a questionnaire about their perceived stigma and satisfaction with their clinician's communication.

BEHAVIORAL

2-hour empathic communication skills training

2-hour empathic communication skills training

BEHAVIORAL

Standardized Patient Assessments

pre-training SPA, post-training SPA

BEHAVIORAL

Training evaluation

Clinicians will complete an evaluation assessing the empathic communication training module.

BEHAVIORAL

Patient recruitment

6 of the clinician's patients (3 pre-training, 3 post-training) will be recruited to complete brief surveys assessing clinician communication

Sponsors & Collaborators

  • Hamad Medical Corporation

    collaborator INDUSTRY
  • University of Arizona

    collaborator OTHER
  • Weill Medical College of Cornell University

    collaborator OTHER
  • University of Florida

    collaborator OTHER
  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Jamie Ostroff, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02732834 on ClinicalTrials.gov